Chemical industry – Page 55
-
BusinessIndia’s Intas bags UK and Irish generics
Teva sheds former Actavis business to satisfy competition requirements of its Allergan generics takeover
-
BusinessPfizer to sell Hospira Infusion Systems to ICU Medical
$1bn deal brings together medical device units, as Pfizer focuses on Hospira’s biosimilars and generics
-
BusinessLilly to buy Boehringer’s pet vaccines
Deal strengthens Lilly’s animal medicine division following recent acquisition
-
FeatureIonic liquids revisted
Ionic liquids have flowed far and wide since they first bubbled to the surface in the late 1990s. Michael Freemantle reports
-
NewsHalf of US business R&D takes place in just five states
National Science Foundation provides state-by-state analysis of $255 billion R&D spend
-
BusinessWest Virginia chemical leak was preventable
2014 spill that contaminated water supplies was caused by lack of proper tank inspections and repairs
-
BusinessNovo Nordisk to axe 1000 jobs
Diabetes specialist is cutting costs in the face of increased competition
-
BusinessAccidents prompt Chinese industry safety push
Government aims to close or relocate chemical plants to reduce incidents in populated areas
-
OpinionBooster shot
Zika and Ebola have highlighted the pharmaceutical industry’s ability to respond to critical needs
-
BusinessLanxess to buy Chemtura for additives
€2.4 billion deal brings lubricant additives and flame retardants expertise and expands North American operations
-
BusinessPfizer scraps plans to split
Previously separated ‘innovative’ and ‘value’ business segments will remain autonomous under Pfizer umbrella
-
NewsPharma giants commit to tackling antimicrobial resistance
Plan to tackle superbugs includes changes to manufacturing and sales incentives
-
BusinessIneos lands first US shale gas in UK
Massive tankers create a ‘virtual pipeline’ bringing feedstock to replace dwindling domestic supplies
-
BusinessUS senators examine agrochem consolidation
Judiciary committee voices concern over pending merger deals
-
BusinessAcquisition spree moves Allergan towards innovative drugs
Company acquires five companies in six weeks across three disease areas
-
BusinessSanofi sues Merck & Co over biosimilars
Merck challenges insulin patents, but Sanofi claims infringement
-
OpinionSlimmer synthesis
Atom economy is a noble aim, but there are other routes to efficient molecule making
-
BusinessJ&J to buy Abbott Medical Optics
Deal adds laser surgery and cataract lens replacements to J&J’s eyecare business
-
BusinessDanaher boosts diagnostics with Cepheid buyout
$4bn deal strengthens Danaher’s life sciences portfolio
-
BusinessFDA’s first Duchenne drug approval reveals schism
Oligonucleotide drug reaches market amid pressure from patient families and strife over ‘patient-focused drug development’ at the regulator